These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9537880)

  • 1. Effect of inhaled formoterol and budesonide on exacerbations of asthma.
    Salvi S
    N Engl J Med; 1998 Apr; 338(15):1072. PubMed ID: 9537880
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
    N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lost in the labyrinth of end points.
    Lipworth BJ
    Chest; 2001 Jul; 120(1):323-4. PubMed ID: 11451868
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
    Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
    Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eformoterol and bronchial hyperresponsiveness in mild asthma.
    Chung KF
    Br J Clin Pract Suppl; 1995 Sep; 81():14-5. PubMed ID: 8546888
    [No Abstract]   [Full Text] [Related]  

  • 6. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice.
    Demoly P; Louis R; Søes-Petersen U; Naya I; Carlsheimer A; Worth H; Almeida J; Sears MR
    Respir Med; 2009 Nov; 103(11):1623-32. PubMed ID: 19762222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide plus formoterol for reliever therapy in asthma.
    Pedersen S
    Lancet; 2006 Aug; 368(9537):707-8. PubMed ID: 16935666
    [No Abstract]   [Full Text] [Related]  

  • 8. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
    Ceylan E; Gencer M; Aksoy S
    Respiration; 2004; 71(6):594-601. PubMed ID: 15627870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic interventions to reduce the risk of asthma exacerbations.
    O'Byrne PM
    Proc Am Thorac Soc; 2004; 1(2):105-8. PubMed ID: 16113421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide + formoterol: new dose regimen. Asthma attacks: a step backwards.
    Prescrire Int; 2008 Apr; 17(94):57. PubMed ID: 18516807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of inhaled formoterol and budesonide on exacerbations of asthma.
    FitzGerald JM
    N Engl J Med; 1998 Apr; 338(15):1071-2; author reply 1072. PubMed ID: 9537879
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of formoterol on light or moderate bronchial asthma due to allergy to Parietaria officinalis].
    Pacor ML; Biasi D; Carletto A; Maleknia T; Lunardi C
    Clin Ter; 1996 Nov; 147(11):567-70. PubMed ID: 9264910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
    Jenkins C; Kolarikova R; Kuna P; Caillaud D; Sanchis J; Popp W; Pettersson E
    Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of the long-acting beta-2 agonist inhalant formoterol on the quality of sleep of patients with bronchial asthma].
    Konermann M; Lück G; Rawert B; Pirsig W
    Pneumologie; 2000 Mar; 54(3):104-9. PubMed ID: 10783649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-acting beta-2-agonists in the treatment of asthma].
    Rochat T
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1714-9. PubMed ID: 7939538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory and functional effects of increasing asthma treatment with formoterol or double dose budesonide.
    Menezes MB; Teixeira AL; Terra Filho J; Vianna EO
    Respir Med; 2008 Oct; 102(10):1385-91. PubMed ID: 18632258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
    Campbell LM
    Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.
    Drug Ther Bull; 2002 Aug; 40(8):62-4. PubMed ID: 12216339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.